^
    BIOMARKER:

    HER-2 negative

    i
    Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2




    Show legend

    Include preclinical:
    HER2 Negative Breast Cancer
    Gastric Cancer
    Gastroesophageal Junction Adenocarcinoma
    Esophageal Cancer
    Esophageal Squamous Cell Carcinoma
    Gastric Adenocarcinoma
    Breast Cancer
    Triple Negative Breast Cancer
    Non Small Cell Lung Cancer
    Gastrointestinal Stromal Tumor
    FP
    GC
    CDK4 inhibitor + CDK6 inhibitor
    AC
    TAC
    GT
    TC
    CaT
    CAPOX
    GemCarbo
    XP
    FEC
    TEC
    EC
    CMF
    cisplatin + capecitabine
    5-fluorouracil + oxaliplatin
    nivolumab
    cisplatin + 5-fluorouracil
    gemcitabine
    vinorelbine tartrate
    pembrolizumab
    rivoceranib
    camrelizumab
    sintilimab + IBI110
    capecitabine + oxaliplatin
    ramucirumab
    anlotinib + APL-502
    tislelizumab
    cadonilimab + AK117
    fam-trastuzumab deruxtecan-nxki
    camrelizumab + rivoceranib
    cisplatin + paclitaxel + capecitabine
    cyclophosphamide + non-pegylated liposomal doxorubicin
    nivolumab + regorafenib
    tislelizumab + rivoceranib
    pegylated liposomal doxorubicin
    envafolimab
    DLYE5953A
    albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim
    rucaparib
    nivolumab + toripalimab-tpzi
    fulvestrant + letrozole
    eribulin mesylate
    ribociclib
    docetaxel
    paclitaxel
    bevacizumab
    albumin-bound paclitaxel
    ixabepilone
    capecitabine
    letrozole
    docetaxel + capecitabine
    tamoxifen
    carboplatin + albumin-bound paclitaxel
    everolimus
    fulvestrant
    fulvestrant + anastrozole
    palbociclib
    abemaciclib
    exemestane
    carboplatin + paclitaxel
    epirubicin
    cyclophosphamide
    doxorubicin hydrochloride
    carboplatin + docetaxel
    POL 6326
    olaparib
    E7389-LF
    alpelisib
    capecitabine + vinorelbine tartrate
    lapatinib
    cabazitaxel
    anlotinib
    MLN8237
    bevacizumab + trastuzumab
    capecitabine + bendamustine
    LY2780301
    paclitaxel oral
    sunitinib
    nivolumab + bevacizumab
    sacituzumab govitecan-hziy
    U3-1402
    trifluridine/tipiracil
    nivolumab + ipilimumab + talimogene laherparepvec
    durvalumab
    toripalimab-tpzi
    capecitabine + cyclophosphamide + methotrexate
    bevacizumab + ME-344
    APG-1387
    gimeracil/oteracil/tegafur
    nedaplatin
    capecitabine + D19466
    docetaxel + doxorubicin hydrochloride
    NLG8189
    trastuzumab
    etoposide IV
    trastuzumab + DIACC3010
    DIACC3010